BPG is committed to discovery and dissemination of knowledge
Home / Archive / Volume 17, Issue 12
  • This Article
Peer-Review Report of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Oncology
ISSN
1948-5204
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study
©The Author(s) 2025.
World J Gastrointest Oncol. Dec 15, 2025; 17(12): 112761
Published online Dec 15, 2025. doi: 10.4251/wjgo.v17.i12.112761
Table 4 Analysis of tumor marker results for two groups of patients
Qinghai NAFLD group (n = 585)
Tianjin NAFLD group (n = 91)
P value
AFP2.245 (1.61, 3.05) 3.36 (2.64, 4.42) < 0.001
CA19-98.705 (6.258, 14.11) 16.53 (8.26, 26.17) < 0.001
CEA1.735 (1.128, 2.75) 1.86 (1.1, 2.79) 0.172
NAFLD: Non-alcoholic fatty liver disease; AFP: Alpha-fetoprotein; CA19-9: Carbohydrate antigen 19-9; CEA: Carcinoembryonic antigen.
Full Size Table
Write to the Help Desk
Copyright © 1993-2026 Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA. All rights reserved, including rights relating to text and data mining, AI training, and similar technologies. For open-access content, the applicable copyright and licensing terms govern.